Table 4.

Safety results using Kaplan–Meier time-to-event analysis

	6 months (number at riska: 2237)	1 year (number at riska: 2112)	2 years (number at riska: 1917)	3 years (number at riska: 1345)
Death	0.5 (10)	1.3 (28)	2.8 (54)	4.1 (59)
Cardiovascular events
Cardiovascular death	0.3 (6)	0.8 (16)	1.5 (28)	2.0 (29)
Stroke	0.7 (15)	1.3 (27)	2.1 (41)	3.2 (47)
Hospitalization for new onset heart failure	0.7 (16)	1.1 (24)	2.0 (38)	3.2 (46)
Hospitalization for atrial fibrillation	0.7 (15)	1.5 (32)	2.4 (46)	3.0 (45)
Hospitalization for hypertensive crisis/hypertensive emergency	0.8 (17)	1.1 (24)	1.8 (36)	2.6 (40)
Myocardial infarction	0.7 (16)	1.1 (23)	1.6 (31)	2.2 (33)
Renal events
New onset end-stage renal disease	0.2 (4)	0.4 (9)	1.0 (19)	1.6 (23)
Serum creatinine elevation >50% mg/dL	0.4 (9)	0.9 (19)	1.2 (24)	1.5 (24)
New artery stenosis (>70% diameter stenosis)	0.05 (1)	0.1 (3)	0.2 (4)	0.3 (4)
Post-procedural events
Non-cardiovascular death	0.1 (2)	0.3 (7)	1.0 (19)	1.6 (22)
Renal artery reintervention	0.2 (5)	0.4 (8)	0.4 (9)	0.6 (10)

Data are presented as Kaplan–Meier estimate % (number of events).

^aNumber at risk at the start of each new follow-up period.